NCT02889172

Brief Summary

The purpose of this study is apply a Brief Intervention (PST) in Diabetic and Obesity patient in primary care of Mexico City to improve their depressive and anxious symptoms and stabilization of metabolic variables.

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
70

participants targeted

Target at P25-P50 for not_applicable diabetes-mellitus-type-2

Timeline
Completed

Started Feb 2015

Longer than P75 for not_applicable diabetes-mellitus-type-2

Geographic Reach
1 country

1 active site

Status
terminated

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

February 1, 2015

Completed
3 months until next milestone

First Submitted

Initial submission to the registry

April 30, 2015

Completed
1.4 years until next milestone

First Posted

Study publicly available on registry

September 5, 2016

Completed
2.5 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 1, 2019

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

March 1, 2019

Completed
Last Updated

September 28, 2023

Status Verified

September 1, 2023

Enrollment Period

4.1 years

First QC Date

April 30, 2015

Last Update Submit

September 26, 2023

Conditions

Outcome Measures

Primary Outcomes (1)

  • Beck Depression Inventory

    The Beck Depression Inventory is a questionnaire of 21 items , is a self- applied instrument ; and determines the severity of depression in a Likert scale ranging from 0 to 4 points ; the minimum score is 0 and the maximum of 63 points : 0-13 = minimal depression ; 14-19 = mild depression ; 20-28 = moderate depression ; 29-63 = severe depression . This instrument has been used in several international studies and in Mexico showing validity and reliability.

    Six months

Secondary Outcomes (2)

  • Beck Anxiety Inventory

    Six Months

  • Simplified Medication Adherence Questionnaire

    Six Months

Study Arms (2)

Problem Solving Therapy

EXPERIMENTAL

Will be apply a Brief Intervention (PST) for patients with Type II Diabetes Mellitus and Obesity who receive treatment in primary care centers from Mexico City. The aim is evaluate if PST improvement the depressive and anxiety symptoms and help to adhere to treatment and stabilize their metabolic variables

Behavioral: Problem Solving Therapy

Control

NO INTERVENTION

This group will receive the usual treatment , without intervention with Brief Intervention ( PST )

Interventions

It will be apply a Brief Intervention (PST) for patients with Type II Diabetes Mellitus and Obesity who receive treatment in primary care centers from Mexico City to evaluate if PST improvement the depressive and anxiety symptoms and help to adhere to treatment and stabilize their metabolic variables

Problem Solving Therapy

Eligibility Criteria

Age35 Years - 70 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • years old
  • Female and male
  • Type II Diabetes Mellitus
  • Obesity (BMI ≥ 30)
  • K-10 ≥ 21 points
  • Beck Depression Inventory 13 to ≤ 28 points
  • Beck Anxiety Inventory 7 to ≤ 25 points
  • Informed consent accepted and signed

You may not qualify if:

  • Severe depression or suicidal ideation
  • Type I Diabetes Mellitus
  • Elimination criteria
  • Questionnaires and scales incomplete
  • Two sessions of PST missing
  • Exacerbation of depressive and / or anxious symptoms during the intervention or monitoring

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Instituto Nacional de Psiquiatría Dr. Ramón de la Fuente

Mexico City, 14370, Mexico

Location

MeSH Terms

Conditions

Diabetes Mellitus, Type 2

Condition Hierarchy (Ancestors)

Diabetes MellitusGlucose Metabolism DisordersMetabolic DiseasesNutritional and Metabolic DiseasesEndocrine System Diseases

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
PARTICIPANT
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
PhD

Study Record Dates

First Submitted

April 30, 2015

First Posted

September 5, 2016

Study Start

February 1, 2015

Primary Completion

March 1, 2019

Study Completion

March 1, 2019

Last Updated

September 28, 2023

Record last verified: 2023-09

Locations